Related Experiment Video
Updated: Jul 28, 2026
11:29
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
Published on: October 3, 2012
Specific 14-3-3 isoform detection and immunolocalization in prion diseases
H C Baxter1, J R Fraser, W-G Liu
1Department of Biomedical Sciences, University of Edinburgh, George Square, Edinburgh EH8 9XD, UK. hbaxter@ed.ac.uk
Biochemical Society Transactions
|August 28, 2002
Summary
Changes in 14-3-3 protein location within the brain and cerebrospinal fluid (CSF) correlate with scrapie disease progression. Detecting specific 14-3-3 isoforms in CSF may aid neurodegenerative disease diagnosis.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- 14-3-3 proteins are crucial signaling molecules in neuronal cells.
- Their altered expression and localization are implicated in various neurological conditions.
Purpose of the Study:
- To investigate the changes in 14-3-3 protein isoform neurolocation in normal versus scrapie-infected murine brains.
- To determine if specific 14-3-3 isoforms in cerebrospinal fluid (CSF) can serve as biomarkers for neurodegenerative diseases.
Main Methods:
- Utilized isoform-specific antibodies to examine 14-3-3 protein distribution in murine brain tissue.
- Employed Western-blot analysis and ELISA to detect and quantify the gamma 14-3-3 isoform in CSF.
Main Results:
- Significant alterations in 14-3-3 isoform neurolocation were observed in specific brain regions of scrapie-infected mice.
- The presence of 14-3-3 proteins in CSF was linked to neuronal disease.
- A correlation was established between Western-blot and ELISA assays for gamma 14-3-3 isoform detection in CSF.
Conclusions:
- 14-3-3 protein neurolocation varies significantly with scrapie pathology in the murine brain.
- Detection of specific 14-3-3 isoforms, particularly gamma 14-3-3, in CSF shows potential for diagnosing neurodegenerative diseases.
- Validated Western-blot and ELISA methods for CSF 14-3-3 isoform analysis.
